“…Based on prior studies9,14,18,19 and data available in WIHS, the following visit-specific time-varying variables (unless otherwise stated) were selected as predictors for CAM disclosure: (1) sociodemographic characteristics included age in years (<35, 35–45 and >45), racial/ethnic identification (non-Hispanic Black, non-Hispanic White, Hispanic and others), and educational level (less than high school, some high school, or college and above) at study index visit, as well as annual income (>$12,000 or not), employment status, and any medical insurance coverage at each visit; (2) health care utilization indicators included number of health care provider visits (<2, 2–3, 4–5, and 6+), any hospitalization, number of CAM domains (1, 2, 3, and 4) and different type of CAM domain used since last visit; (3) functional status of participants consisted of depressive symptoms (measured by using the Center for Epidemiologic Studies Depression Scale [CESD],20 with a score 16 or higher defined as depression) and overall health-related quality of life (QOL, measured on a scale from 0 to 100 using a modified version of the MOS-HIV21 and was categorized using tertiles); (4) patient satisfaction was evaluated using the RAND Patient Satisfaction Questionnaire Short Form (PSQ-18), which has demonstrated validity and reliability among individuals with HIV/AIDS 22,23. We used the general satisfaction domain (categorized by quartiles) of this instrument to represent participants’ overall satisfaction with health care received; (5) clinical variables included CD4 + T cell counts (measured using standardized three or four color flow cytometry24), HIV RNA level (measured using the isothermal nucleic acid sequence based amplification method [bioMérieux, Boxtel, NL]), number of HIV-related symptoms (including fever, memory/concentration problem, diarrhea, numbness/tingling/burning rash, unintentional weights loss, difficulty with mental tasks, drenching night sweats, and divided into four categories 0, 1, 2, >2), clinical AIDS diagnosis (1993 criteria25), as well as use of antiretroviral therapy (no therapy, non-HAART therapy, and HAART).…”